## [LinkedIn 15Feb26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_claudecode-nvidiagtc-activity-7429050372591206400-Lwat)

Repository: Note Purpose 1)

Weekend of Claude Code Excellence.

Purpose: 1) Update a repository in progress with images to better visualize its content. 2) Improve a second existing repository for enhanced repository structure visibility

Plan: Friday 2/13
- Prompt plan.md was utilized for generating thirty visualization text instructions based on physical-ai-oncology-trials repository data, using claude plan: https://lnkd.in/gr3pvG8B

Saturday 2/14
- Prompt 1st.md was executed in a San Diego live online demo to obtain the first ten visualizations (ten .py, twenty .html, twenty .png; light and dark mode plotly images)
- Prompt 2nd.md and Prompt 3rd.md were run by user, which provided 11-20 and 21-30 visualizations with corresponding .py, .html, and .png files

Sunday 2/15
- Additional README.md updates and manual fixes in Prompt update.md v1.3.0
- Cambridge, MA live online demo of an existing LLMs-Pharmaceutical repository-wide README restructuring and additional file additions under main using V4.2.0_PROMPT.md: https://lnkd.in/g8RJpsae

Experimental:
- Demonstrations, prompt creation and submissions were conducted on a single mobile device (iPhone 15 pro)
- All prompts were created manually by the user. Claude Code was executed using mobile Safari
- Additional small prompts were submitted to Claude Code (Opus 4.6) as needed if interface stalled momentarily 
- 5 prompts over two repos: High efficiency, no re-runs. Single user, three day turnaround 
- Images were typically returned with formatted titles and axis, minor spacing issues, no significant text or object overlap was observed, only two of sixty images were blank
- Images typically reflected context from repository, as directed in earlier AI prompts 

- Visualization prompt creation methods were further optimized from prior 2025 publications that used standard Claude.ai (10 visualizations max, higher error rates, chart formatting issues, separate image processing step, re-runs): https://lnkd.in/ggGb_B_b

- Main feedback from colleagues at the 12/14 event was regarding the validity of the Claude Code outputs. My response was a directory of extensive tests performed in an earlier version https://lnkd.in/grQESMwk; Further testing is explained here: Claude Code checks and regulatory implementations (v1.2.1, v1.0.1), logic audit (v0.9.2), and static analysis (v0.9.1)

- Feedback from a 12/15 colleague surrounded on how prompts were being documented. My response was that main prompts used in papers were shared in the work, and that the current repository would also include prompts.

- Conclusion: In 5 prompts, Claude Code successfully added 58 physical ai oncology-related images, in part to a live audience; and completed a repository structure outline across an existing 2300 file code repository (single weekend, mobile device).

#claudecode, #NVIDIAGTC, Bryan Catanzaro



## [LinkedIn 10Feb26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_nvidiagtc-claudecode-codex-activity-7427259844837101568-RPBK)

Right now is the turning point for physical ai oncology trials due to broad support of the ai technology by leaders. NVIDIA CEO Jensen Huang used CES 2026 to argue that robotics is approaching its “ChatGPT moment,” and backed it with developments aimed at making robots more repeatable. (1) Upcoming announcements for the NVIDIA GTC in March 2026 feature improvements in robotic agility capabilities. (2) Tesla CEO Elon Musk stressed that the U.S. is ‘1,000% going to go bankrupt’ unless AI and robotics save the economy. (3)

Oncology trial robots will utilize a range of machine learning: self-supervised, supervised, and reinforcement learning for loco-manipulation. For human-level intelligence: generative ai and agentic ai are used for both onboard tasks and comprehensive LLM processing in the cloud (claude code, codex, gemini). 

Physical-ai-oncology-trials v1.0.0 is the unification framework for oncology trial machine learning, simulation & physics (mujoco, isaac lab), surgical robots, digital twins (with code), and a complete privacy/regulatory compliance infrastructure. This includes 51 Python source files, 69 markdown files, 28 production-ready examples, 5 standalone cli tools, and Q1 2026 standards for unifying isaac ↔ mujoco bidirectional conversion, robot model validations, and a benchmarking suite. 

Please star the repository and share with pharmaceutical and regulatory leaders : https://lnkd.in/gr3pvG8B


#NVIDIAGTC, #ClaudeCode, #Codex

References:
1) Jensen Huang: https://lnkd.in/gk3qQU4X
2) NVIDIA: https://lnkd.in/gnufKJ8n
3) Elon Musk: https://lnkd.in/gwgwdvaj



## [LinkedIn 08Feb26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_v100-first-stable-release-end-to-end-activity-7426405053948649472-rRRm)

v1.0.0 - First Stable Release: End-to-End Physical AI Unification of Oncology Clinical Trials

Summary
First stable release of the Physical AI for Oncology Clinical Trials repository. This release designates the public API — directory structure, module interfaces, CLI tool contracts, and configuration formats — as stable under Semantic Versioning 2.0.0. The repository delivers 51 Python source files (40,526 LOC), 69 markdown documentation files (18,922 lines), 28 production-ready examples, 5 standalone CLI tools, and complete privacy/regulatory compliance infrastructure, all CI-validated across Python 3.10, 3.11, and 3.12.

Features
Unification framework: Isaac-MuJoCo bridge, URDF/SDF/MJCF/USD model converter, unified agent interface, cross-platform validation suite, and framework auto-detector enabling seamless interoperability between NVIDIA Isaac Lab, MuJoCo, Gazebo, and PyBullet

28 production-ready examples: 5 AI/ML pipeline examples (surgical training, digital twins, cross-framework validation, agentic workflows, treatment prediction), 6 physical robot hardware examples (safety monitoring, sensor fusion, ROS 2 deployment, hand-eye calibration, shared autonomy, robotic sample handling), 6 digital twin engineering examples (real-time synchronization, multi-organ toxicity, adaptive radiation therapy, immunotherapy modeling, virtual trial cohorts, V&V framework), 6 agentic AI examples (MCP server, ReAct planning, real-time adaptive agents, simulation orchestration, safety-constrained execution, RAG compliance), and 5 production examples

5 CLI tools: DICOM inspector with PHI audit, radiotherapy dose calculator (BED/EQD2/TCP/NTCP), multi-site trial monitor, cross-framework simulation job runner, and deployment readiness checker

Privacy framework: PHI/PII detection (18 HIPAA identifiers), Safe Harbor and Expert Determination de-identification, role-based access control with 21 CFR Part 11 audit trails, automated breach response, and Data Use Agreement generation

Regulatory framework: FDA submission tracking (510(k), De Novo, PMA, Breakthrough), IRB protocol management, ICH E6(R3) compliance verification, and multi-jurisdiction regulatory intelligence

Digital twin pipelines: TumorTwin integration for patient-specific tumor modeling, PK/PD treatment simulation, and FHIR/DICOM clinical integration

Q1 2026 Standards: 3 proposed community standards for bidirectional framework conversion, unified robot model repository, and validation benchmark suite

Security hardened: Pickle deserialization fixes (torch.load, numpy.load), cryptographic salt generation, audit log immutability, access control deny-by-default

13 critical logic bugs fixed: EKF Jacobian sign error, inverted hazard ratio, infinite evaluation loop, division-by-zero conditions, dead-code renal elimination, and more (see CHANGELOG.md v0.9.1 and v0.9.2)

Release Notes: https://lnkd.in/g-qa5qKS

Documentation: https://lnkd.in/gvYfs9YS



## [LinkedIn 06Feb26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_engineers-building-robotic-systems-may-find-activity-7425601873006702592-TM4v)

Engineers building robotic systems may find value in the following Python scripts from physical-ai-oncology-trials: https://lnkd.in/g34_i-SN

examples/
01_surgical_robot_training py
02_digital_twin_surgical_planning py
03_cross_framework_validation py
04_agentic_clinical_workflow py
05_treatment_response_prediction py

examples-new/
01_realtime_safety_monitoring py
02_sensor_fusion_intraoperative py
03_ros2_surgical_deployment py
04_hand_eye_calibration_registration py
05_shared_autonomy_teleoperation py
06_robotic_sample_handling py

q1-2026-standards/objective-1/
isaac_to_mujoco_pipeline py
mujoco_to_isaac_pipeline py
physics_equivalence_tests py
objective-2/model_validator py
objective-3/benchmark_runner py




## [LinkedIn 04Feb26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_worldcancerday-oncologytrials-physicalai-activity-7424912253612765185-jzSJ)

Dear colleague, I have lost people who were close to me over the years to cancer. However, these events were retold as if the disease was nearly impossible to cure. Later in life, I worked on a medicinal transport project with the goal of cancer treatments effectively reaching tumors; and I have had the opportunity to work on oncology studies addressing adverse events, patient selection, and clinical trial simulations for glioblastoma/pancreatic cancer.

The largest factor I have found to now speed up the physical ai oncology drug approval process is to increase the reliance on code generation processes with LLMs to simulate and run code on robots. The magical aspect of code generation for me continues to be the speed through iterations to reach higher quality code faster than humans; rather than inherent advantages in the generated code itself. Breakthroughs based on the principle of fixing and optimizing code are pivotal to train and deploy medical humanoids faster. Therefore, these speedups in software are anticipated to cause commensurate breakthroughs in physical systems.

To this effect, the physical ai oncology clinical trial landscape is overdue for a full unification accomplished through engineers who have the tools for smarter, more agile, and more intelligent robots through a recent repository (https://lnkd.in/g34_i-SN). This repository provides production-ready configurations, validated pipelines, and integration guides for quickly deploying robotic systems, digital twins, and embodied AI agents in oncology. Please star or share the open source work for physical ai oncology clinical trial acceleration. 

Recent versions include:
v0.5.1 - Standardize Repo with GitHub Community Health Files and CI
v0.5.0 - Add Privacy and Regulatory Directories for Physical AI Oncology Trials
v0.4.0 - Add Digital-Twins and Examples Directories for Oncology Trials
v0.3.2 - Update Repository Context with Latest Physical AI Technologies
v0.3.1 - Fix Outdated Versions and Add Source Citations Across Repository

#worldcancerday, #oncologytrials, #physicalai 



## [LinkedIn 31Jan26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_isaaclab-mujoco-gazebo-activity-7423587151914713088--y4W)

A physical ai oncology clinical trial unification roadmap has been developed to accelerate adoption of a) simulation physics, b) agentic/generative ai, c) surgical robots, and d) cross platform tools: https://lnkd.in/gr3pvG8B. 

Specifically, this open source platform provides tools, standards, and workflows necessary to develop the future of physical ai uniformity: 
a) Switch between simulation frameworks (NVIDIA Isaac, MuJoCo, Gazebo, PyBullet) at any stage
b) Integrate agentic and generative AI across different robotic platforms
c) Share surgical robotics models across organizations with standardized formats
d) Collaborate on multi-site clinical trials with unified data and control interfaces

Current simulation features such as parallelized gpu simulation, ROS 2 compliance, and ray tracing are not compatible across frameworks. Physics force readings can have variance: ±12% across PhysX, MuJoCo, and PyBullet - unacceptable for safety-critical applications.

Unified components seek to maintain:
1) FDA 21 CFR Part 11 audit trail capability
2) ICH E6(R2) GCP compliance hooks
3) ISO 13482 safety robot requirements
4) IEC 62304 software lifecycle traceability

Timeline goals for Q1 2026 include a complete Isaac ↔ MuJoCo bidirectional conversion and a unified robot model repository. Q2-Q4 2026 goals include GR00T adapters, a multi-site clinical trial coordination platform, and production deployment at 3+ healthcare systems. 

#isaaclab, #mujoco, #gazebo, #mjlab, #crewai, #langchain, #mcp 




## [LinkedIn 31Jan26 Post](https://www.linkedin.com/posts/kevin-kawchak-38b52a4a_this-repository-was-generated-by-opus-45-activity-7423479519455662080-wpsO)

This repository was generated by Opus 4.5 Cowork to detail the modern agentic and generative ai tools impacting oncology physical ai primarily based on new or updated works from October 2025 - January 2026. For each of the reinforcement learning, self-supervised learning, and supervised learning directories: strengths.md, limitations.md, and results.md are provided for guidance. 

Additional integration.md files for gazebo, mujoco, nvidia-isaac, and pybullet feature overviews, installation instructions, simulation code, and other configuration/train/controller scripts. This is by no means a comprehensive guide for physical ai use, but rather a modern guide to build physical ai oncology trials based on impacting technologies and frameworks.

Kevin Kawchak. (2026). kevinkawchak/physical-ai-oncology-trials: v0.1.0 - Initial Zenodo release (January 2026 snapshot). https://lnkd.in/g34_i-SN

- All Posts by Kevin Kawchak
